Validation of the Rome Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbation: A Multicenter Cohort Study
Jiaxin Zeng,Chen Zhou,Qun Yi,Yuanming Luo,Hailong Wei,Huiqing Ge,Huiguo Liu,Jianchu Zhang,Xianhua Li,Pinhua Pan,Mengqiu Yi,Lina Cheng,Liang Liu,Jiarui Zhang,Lige Peng,Jiaqi Pu,Haixia Zhou
DOI: https://doi.org/10.2147/copd.s442382
2024-01-18
International Journal of COPD
Abstract:Jiaxin Zeng, 1, &ast Chen Zhou, 2, &ast Qun Yi, 1, 3 Yuanming Luo, 4 Hailong Wei, 5 Huiqing Ge, 6 Huiguo Liu, 7 Jianchu Zhang, 8 Xianhua Li, 9 Pinhua Pan, 10 Mengqiu Yi, 11 Lina Cheng, 11 Liang Liu, 12 Jiarui Zhang, 1 Lige Peng, 1 Jiaqi Pu, 1 Haixia Zhou 1 On behalf of the MAGNET AECOPD Registry Investigators 1 Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, People's Republic of China; 2 Center of Infectious Diseases, Division of Infectious Diseases in State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, People's Republic of China; 3 Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan Province, People's Republic of China; 4 State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China; 5 Department of Respiratory and Critical Care Medicine, People's Hospital of Leshan, Leshan, Sichuan Province, People's Republic of China; 6 Department of Respiratory and Critical Care Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People's Republic of China; 7 Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China; 8 Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China; 9 Department of Respiratory and Critical Care Medicine, The First People's Hospital of Neijiang City, Neijiang, Sichuan Province, People's Republic of China; 10 Department of Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, Hunan Province, People's Republic of China; 11 Department of Emergency, First People's Hospital of Jiujiang, Jiu jiang, Jiangxi Province, People's Republic of China; 12 Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Chengdu University, Chengdu, Sichuan Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Haixia Zhou, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Guo-Xue-Xiang 37&num, Wuhou District, Chengdu, Sichuan Province, 610041, People's Republic of China, Tel/Fax +86-28-85422571, Email Background: The Rome severity classification is an objective assessment tool for the severity of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) based on readily measurable variables but has not been widely validated. The aim of this study is to evaluate the validity of the Rome classification in distinguishing the severity of AECOPD based on short-term mortality and other adverse outcomes. Methods: The Rome severity classification was applied to a large multicenter cohort of inpatients with AECOPD. Differences in clinical features, in-hospital and 60-day mortality, intensive care unit (ICU) admission, mechanical ventilation (MV) and invasive mechanical ventilation (IMV) usage were compared among the mild, moderate and severe AECOPD according to the Rome proposal. Moreover, univariate logistic analysis and Kaplan Meier survival analysis were also performed to find the association between the Rome severity classification and those adverse outcomes. Results: A total of 7712 patients hospitalized for AECOPD were included and classified into mild (41.88%), moderate (40.33%), or severe (17.79%) group according to the Rome proposal. The rate of ICU admission (6.4% vs 12.0% vs 14.9%, P < 0.001), MV (11.7% vs 33.7% vs 45.3%, P < 0.001) and IMV (1.4% vs 6.8% vs 8.9%, P < 0.001) increased significantly with the increase of severity classification from mild to moderate to severe AECOPD. The 60-day mortality was higher in the moderate or severe group than in the mild group (3.5% vs 1.9%, 4.3% vs 1.9%, respectively, P 0.05), results for in-hospital mortality showed the same trends. Similar findings were observed by univariate logistic analysis and survival analysis. Conclusion: Rome severity classification demonstrated excellent performance in predicting ICU admission and the need for MV or IMV, but how -Abstract Truncated-
respiratory system